135 related articles for article (PubMed ID: 19695222)
41. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.
Hasumi Y; Baba M; Ajima R; Hasumi H; Valera VA; Klein ME; Haines DC; Merino MJ; Hong SB; Yamaguchi TP; Schmidt LS; Linehan WM
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18722-7. PubMed ID: 19850877
[TBL] [Abstract][Full Text] [Related]
42. Hamartin and tuberin: working together for tumour suppression.
Jozwiak J
Int J Cancer; 2006 Jan; 118(1):1-5. PubMed ID: 16206276
[TBL] [Abstract][Full Text] [Related]
43. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.
Goncharova EA; Goncharov DA; James ML; Atochina-Vasserman EN; Stepanova V; Hong SB; Li H; Gonzales L; Baba M; Linehan WM; Gow AJ; Margulies S; Guttentag S; Schmidt LS; Krymskaya VP
Cell Rep; 2014 Apr; 7(2):412-423. PubMed ID: 24726356
[TBL] [Abstract][Full Text] [Related]
44. GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
Buller CL; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F588-96. PubMed ID: 21613414
[TBL] [Abstract][Full Text] [Related]
45. Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway.
Jozwiak J; Jozwiak S; Grzela T; Lazarczyk M
Neuromolecular Med; 2005; 7(4):287-96. PubMed ID: 16391386
[TBL] [Abstract][Full Text] [Related]
46. Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.
Sager RA; Woodford MR; Shapiro O; Mollapour M; Bratslavsky G
Oncotarget; 2018 Apr; 9(31):22220-22229. PubMed ID: 29774133
[TBL] [Abstract][Full Text] [Related]
47. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W
Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670
[TBL] [Abstract][Full Text] [Related]
48. FLCN is a novel Rab11A-interacting protein that is involved in the Rab11A-mediated recycling transport.
Zhao L; Ji X; Zhang X; Li L; Jin Y; Liu W
J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30446510
[TBL] [Abstract][Full Text] [Related]
49. Rheb and Rags come together at the lysosome to activate mTORC1.
Groenewoud MJ; Zwartkruis FJ
Biochem Soc Trans; 2013 Aug; 41(4):951-5. PubMed ID: 23863162
[TBL] [Abstract][Full Text] [Related]
50. Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines.
Glykofridis IE; Henneman AA; Balk JA; Goeij-de Haas R; Westland D; Piersma SR; Knol JC; Pham TV; Boekhout M; Zwartkruis FJT; Wolthuis RMF; Jimenez CR
Mol Cell Proteomics; 2022 Sep; 21(9):100263. PubMed ID: 35863698
[TBL] [Abstract][Full Text] [Related]
51. mTORC1 signaling: what we still don't know.
Wang X; Proud CG
J Mol Cell Biol; 2011 Aug; 3(4):206-20. PubMed ID: 21138990
[TBL] [Abstract][Full Text] [Related]
52. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
Hasumi H; Baba M; Hasumi Y; Huang Y; Oh H; Hughes RM; Klein ME; Takikita S; Nagashima K; Schmidt LS; Linehan WM
J Natl Cancer Inst; 2012 Nov; 104(22):1750-64. PubMed ID: 23150719
[TBL] [Abstract][Full Text] [Related]
53. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
[TBL] [Abstract][Full Text] [Related]
54. Structural mechanism of a Rag GTPase activation checkpoint by the lysosomal folliculin complex.
Lawrence RE; Fromm SA; Fu Y; Yokom AL; Kim DJ; Thelen AM; Young LN; Lim CY; Samelson AJ; Hurley JH; Zoncu R
Science; 2019 Nov; 366(6468):971-977. PubMed ID: 31672913
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in the regulation of the TOR pathway by insulin and nutrients.
Avruch J; Lin Y; Long X; Murthy S; Ortiz-Vega S
Curr Opin Clin Nutr Metab Care; 2005 Jan; 8(1):67-72. PubMed ID: 15586002
[TBL] [Abstract][Full Text] [Related]
56. The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe.
van Slegtenhorst M; Khabibullin D; Hartman TR; Nicolas E; Kruger WD; Henske EP
J Biol Chem; 2007 Aug; 282(34):24583-90. PubMed ID: 17556368
[TBL] [Abstract][Full Text] [Related]
57. Role of FLCN Phosphorylation in Insulin-Mediated mTORC1 Activation and Tumorigenesis.
Wang G; Chen L; Lei X; Qin S; Geng H; Zheng Y; Xia C; Yao J; Meng T; Deng L
Adv Sci (Weinh); 2023 Jun; 10(17):e2206826. PubMed ID: 37083230
[TBL] [Abstract][Full Text] [Related]
58. Ciliary localization of folliculin mediated via a kinesin-2-binding motif is required for its functions in mTOR regulation and tumor suppression.
Zhang Y; Liu Y; Dai Y; Ren Y; Bao G; Ai B; Jiang Y
FEBS Lett; 2021 Jan; 595(1):123-132. PubMed ID: 33064845
[TBL] [Abstract][Full Text] [Related]
59. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.
Yan M; Gingras MC; Dunlop EA; Nouët Y; Dupuy F; Jalali Z; Possik E; Coull BJ; Kharitidi D; Dydensborg AB; Faubert B; Kamps M; Sabourin S; Preston RS; Davies DM; Roughead T; Chotard L; van Steensel MA; Jones R; Tee AR; Pause A
J Clin Invest; 2014 Jun; 124(6):2640-50. PubMed ID: 24762438
[TBL] [Abstract][Full Text] [Related]
60. Nutrient Signaling and Lysosome Positioning Crosstalk Through a Multifunctional Protein, Folliculin.
de Martín Garrido N; Aylett CHS
Front Cell Dev Biol; 2020; 8():108. PubMed ID: 32195250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
